Cell Lysis Market Set for Steady Growth, Driven by Biopharma R&D and Genomics Advances
• Global cell lysis market valued at $3.04 billion in 2022, expected to grow at 6.79% CAGR through 2028 • Driven by cell-based research, genomics/proteomics advances, biopharma drug development • North America holds dominant position due to healthcare infrastructure, research ecosystem • Reagents segment had major 2022 market share, essential for cell lysis process • Emerging trends tied to biologics demand, personalized medicine requiring precise cell lysis techniques